Bone marrow mesenchymal stem cells accelerate the hyperglycemic refractory wound healing by inhibiting an excessive inflammatory response

Nan,Wenbin; Xu,Zhihao; Chen,Zhibin; Yuan,Xin; Lin,Juntang; Feng,Huigen; Lian,Jie; Chen,Hongli

doi:10.3892/mmr.2017.6400

Bone marrow mesenchymal stem cells accelerate the hyperglycemic refractory wound healing by inhibiting an excessive inflammatory response

Authors:
- Wenbin Nan
- Zhihao Xu
- Zhibin Chen
- Xin Yuan
- Juntang Lin
- Huigen Feng
- Jie Lian
- Hongli Chen
View Affiliations

Affiliations: Department of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China, Research Center of Stem Cell and Biotherapy Technology, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China
Published online on: March 28, 2017 https://doi.org/10.3892/mmr.2017.6400
Pages: 3239-3244

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to evaluate the healing effect of bone marrow-derived mesenchymal stem cells administered to hyperglycemia model mice with skin wounds, and to explore the underlying mechanism contributing to their effects in promoting refractory wound healing. A full‑thickness skin wound mouse model was established, and refers to a wound of the skin and subcutaneous tissue. The mice were randomly divided into three groups: Blank control group, hyperglycemic group and a hyperglycemic group treated with stem cells. Wound healing was monitored and the wound‑healing rate was determined at 3, 6, 9, and 12 days following trauma. The structure of the organization of new skin tissue was observed by hematoxylin and eosin staining, and expression levels of the inflammatory cytokines interleukin (IL)‑6 and tumor necrosis factor (TNF)‑α were determined from 1 to 6 days following trauma. The wound healing of the hyperglycemic group was slower than that of the blank group, and the hyperglycemic mice treated with stem cells presented faster healing than the hyperglycemia group. The horny layer and granular layer of the skin were thinner and incomplete in the new skin tissue of the hyperglycemic group, whereas the new skin wound tissue basal layer was flat and demonstrated better fusion with the wound edge in the other two groups. The expression of inflammatory cytokines (IL‑6 and TNF‑α) was significantly increased in all three groups, with continuously higher expression in the hyperglycemic group and decreased expression in the other two groups over time. Hyperglycemia refractory wounds are likely related to the excessive expression of inflammatory cytokines surrounding the wound area. Stem cells may be able to alleviate the excessive inflammatory reaction in the wound tissue of hyperglycemic mice, so as to promote wound healing.

View Figures

View References

1	Kucisec-Tepes N: Prevention of chronic wound infection. Acta Med Croatica. 67:(Suppl 1). S51–S58. 2013.(In Croatian).
2	Park NJ, Allen L and Driver VR: Updating on understanding and managing chronic wound. Dermatol Ther. 26:236–256. 2013. View Article : Google Scholar : PubMed/NCBI
3	Yazdanpanah L, Nasiri M and Adarvishi S: Literature review on the management of diabetic foot ulcer. World J Diabetes. 6:37–53. 2015. View Article : Google Scholar : PubMed/NCBI
4	Gourevitch D, Kossenkov AV, Zhang Y, Clark L, Chang C, Showe LC and Heber-Katz E: Inflammation and its correlates in regenerative wound healing: An alternate perspective. Adv Wound Care (New Rochelle). 3:592–603. 2014. View Article : Google Scholar : PubMed/NCBI
5	Oberyszyn TM: Inflammation and wound healing. Front Biosci. 12:2993–2999. 2007. View Article : Google Scholar : PubMed/NCBI
6	Gyurko R, Siqueira CC, Caldon N, Gao L, Kantarci A and Van Dyke TE: Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. J Immunol. 177:7250–7256. 2006. View Article : Google Scholar : PubMed/NCBI
7	Nguyen KT, Seth AK, Hong SJ, Geringer MR, Xie P, Leung KP, Mustoe TA and Galiano RD: Deficient cytokine expression and neutrophil oxidative burst contribute to impaired cutaneous wound healing in diabetic, biofilm-containing chronic wounds. Wound Repair Regen. 21:833–841. 2013. View Article : Google Scholar : PubMed/NCBI
8	Jackson WM, Nesti LJ and Tuan RS: Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther. 3:202012. View Article : Google Scholar : PubMed/NCBI
9	Shin L and Peterson DA: Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells. Stem Cells Transl Med. 2:33–42. 2013. View Article : Google Scholar : PubMed/NCBI
10	Zheng L, Chu J, Tan L, Shi Y and Han Y: Immunoregulation of autologous peripheral blood stem cell transplantation in patients with hepatitis B-related end-stage liver disease. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 29:407–410. 2013.(In Chinese). PubMed/NCBI
11	Akiyama K, Chen C, Wang D, Xu X, Qu C, Yamaza T, Cai T, Chen W, Sun L and Shi S: Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell. 10:544–555. 2012. View Article : Google Scholar : PubMed/NCBI
12	Short BJ, Brouard N and Simmons PJ: Prospective isolation of mesenchymal stem cells from mouse compact bone. Methods Mol Biol. 482:259–268. 2009. View Article : Google Scholar : PubMed/NCBI
13	Blanpain C: Stem cells: Skin regeneration and repair. Nature. 464:686–687. 2010. View Article : Google Scholar : PubMed/NCBI
14	Morin C, Roumegous A, Carpentier G, Barbier-Chassefière V, Garrigue-Antar L, Caredda S and Courty J: Modulation of inflammation by Cicaderma ointment accelerates skin wound healing. J Pharmacol Exp Ther. 343:115–124. 2012. View Article : Google Scholar : PubMed/NCBI
15	Minton K: Chemokines: Neutrophils leave a trail for T cells. Nat Rev Immunol. 15:5972015. View Article : Google Scholar : PubMed/NCBI
16	Ariel A, Fredman G, Sun YP, Kantarci A, Van Dyke TE, Luster AD and Serhan CN: Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol. 7:1209–1216. 2006. View Article : Google Scholar : PubMed/NCBI
17	Tian M, Qing C, Niu Y, Dong J, Cao X, Song F, Ji X and Lu S: The relationship between inflammation and impaired wound healing in a diabetic rat burn model. J Burn Care Res. 37:e115–e124. 2016. View Article : Google Scholar : PubMed/NCBI
18	Koh TJ and DiPietro LA: Inflammation and wound healing: The role of the macrophage. Expert Rev Mol Med. 13:e232011. View Article : Google Scholar : PubMed/NCBI
19	Gardian K, Janczewska S, Olszewski WL and Durlik M: Analysis of pancreatic cancer microenvironment: Role of macrophage infiltrates and growth factors expression. J Cancer. 3:285–291. 2012. View Article : Google Scholar : PubMed/NCBI
20	Owen JL and Mohamadzadeh M: Macrophages and chemokines as mediators of angiogenesis. Front Physiol. 4:1592013. View Article : Google Scholar : PubMed/NCBI
21	Rosas-Ballina M, Valdés-Ferrer SI, Dancho ME, Ochani M, Katz D, Cheng KF, Olofsson PS, Chavan SS, Al-Abed Y, Tracey KJ and Pavlov VA: Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation. Brain Behav Immun. 44:19–27. 2015. View Article : Google Scholar : PubMed/NCBI
22	Li HP, Chen X and Li MQ: Gestational diabetes induces chronic hypoxia stress and excessive inflammatory response in murine placenta. Int J Clin Exp Pathol. 6:650–659. 2013.PubMed/NCBI
23	Wang J, Zhou J, Zheng HF and Fu ZZ: Effect of decitabine on immune regulation in patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 22:1448–1452. 2014.(In Chinese). PubMed/NCBI
24	Zhao Y, Huang Z, Qi M, Lazzarini P and Mazzone T: Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell. Immunol Lett. 108:78–87. 2007. View Article : Google Scholar : PubMed/NCBI
25	Chen YT, Sun CK, Lin YC, Chang LT, Chen YL, Tsai TH, Chung SY, Chua S, Kao YH, Yen CH, et al: Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med. 9:512011. View Article : Google Scholar : PubMed/NCBI
26	Moslem M, Eberle I, Weber I, Henschler R and Cantz T: Mesenchymal stem/stromal cells derived from induced pluripotent stem cells support CD34(pos) hematopoietic stem cell propagation and suppress inflammatory reaction. Stem Cells Int. 2015:8430582015. View Article : Google Scholar : PubMed/NCBI